International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A

被引:0
|
作者
Pilette, Charles
Canonica, Giorgio Walter
Chaudhuri, Rekha
Lee, F. Eun-Hyung
Lee, Jason Kihyuk
Sanchez, Carlos Almonacid
Alfonso-Cristancho, Rafael
Jakes, Rupert
Maxwell, Aoife
Price, Robert
Howarth, Peter
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:566 / 566
页数:1
相关论文
共 50 条
  • [21] REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS
    Bagnasco, Diego
    Hill, David G.
    Welte, Tobias
    Chaudhuri, Rekha
    Price, Robert
    Howarth, Peter
    [J]. CHEST, 2023, 164 (04) : 75A - 76A
  • [22] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 50 - 51
  • [23] Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study
    Schleich, F.
    Lougheed, M.
    Matucci, A.
    Hermosa, J. Rodriguez
    Pfeffer, P.
    Verghis, R. M.
    Jakes, R. W.
    Alfonso-Cristancho, R.
    Liu, M. C.
    Welte, T.
    Bals, R.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [25] HEALTHCARE RESOURCE USE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA AFTER THE INITIATION OF MEPOLIZUMAB IN REAL-LIFE SETTINGS - REALITI-A STUDY
    Yang, S.
    Maxwell, A.
    Joksaite, S.
    Chaudhuri, R.
    Pastorello, E. A.
    Lee, J.
    Kohler, T. C.
    Ramos-Barbon, D.
    Schleich, F.
    Steven, G.
    Alfonso, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S361 - S361
  • [26] Mepolizumab Provides Real-World Clinical Benefits in Severe Eosinophilic Asthma Irrespective of Baseline Lung Function: Results From the REALITI-A Study at 2 Years
    Bagnasco, D.
    Pilette, C.
    Lougheed, M.
    Caruso, C.
    Echave-Sustaeta, J.
    Dennison, P.
    Verghis, R.
    Jakes, R.
    Rais, M.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] EFFECTIVENESS AND SAFETY OF MEPOLIZUMAB IN REAL-WORLD CLINICAL PRACTICE: UK PATIENT OUTCOMES FROM THE REALITI-A STUDY
    Kerr, W. A. F.
    Harrison, T. W.
    Loveday, K.
    Joksaite, S.
    Kwon, N.
    [J]. THORAX, 2019, 74 : A140 - A140
  • [28] UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years
    Weir, J.
    Egan, B.
    Heaney, L.
    Menzies, D.
    Pfeffer, P.
    Howarth, P.
    Chaudhuri, R.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A184 - A184
  • [29] Patient and Physician Perspectives on Mepolizumab Treatment in Severe Asthma: Data From the REALITI-A Study
    Lee, Jason
    Canonica, Giorgio
    Caruso, Cristiano
    Chaudhuri, Rekha
    Pilette, Charles
    Price, Robert
    Howarth, Peter
    Lee, F. Eun-Hyung
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB102 - AB102
  • [30] Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A
    Lee, Frances
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15